List of Tables
Table 1. Global Oligonucleotide Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Antisense Oligonucleotide
Table 3. Key Players of Aptamer
Table 4. Key Players of Others
Table 5. Global Oligonucleotide Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Oligonucleotide Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Oligonucleotide Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Oligonucleotide Therapy Market Share by Region (2020-2025)
Table 9. Global Oligonucleotide Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Oligonucleotide Therapy Market Share by Region (2026-2031)
Table 11. Oligonucleotide Therapy Market Trends
Table 12. Oligonucleotide Therapy Market Drivers
Table 13. Oligonucleotide Therapy Market Challenges
Table 14. Oligonucleotide Therapy Market Restraints
Table 15. Global Oligonucleotide Therapy Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Oligonucleotide Therapy Market Share by Players (2020-2025)
Table 17. Global Top Oligonucleotide Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oligonucleotide Therapy as of 2024)
Table 18. Ranking of Global Top Oligonucleotide Therapy Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Oligonucleotide Therapy Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Oligonucleotide Therapy, Headquarters and Area Served
Table 21. Global Key Players of Oligonucleotide Therapy, Product and Application
Table 22. Global Key Players of Oligonucleotide Therapy, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Oligonucleotide Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Oligonucleotide Therapy Revenue Market Share by Type (2020-2025)
Table 26. Global Oligonucleotide Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Oligonucleotide Therapy Revenue Market Share by Type (2026-2031)
Table 28. Global Oligonucleotide Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Oligonucleotide Therapy Revenue Market Share by Application (2020-2025)
Table 30. Global Oligonucleotide Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Oligonucleotide Therapy Revenue Market Share by Application (2026-2031)
Table 32. North America Oligonucleotide Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Oligonucleotide Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Oligonucleotide Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Oligonucleotide Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Oligonucleotide Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Oligonucleotide Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Oligonucleotide Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Oligonucleotide Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Oligonucleotide Therapy Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Oligonucleotide Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Oligonucleotide Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Oligonucleotide Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Oligonucleotide Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Oligonucleotide Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Oligonucleotide Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 47. Alnylam Pharmaceuticals Inc. Company Details
Table 48. Alnylam Pharmaceuticals Inc. Business Overview
Table 49. Alnylam Pharmaceuticals Inc. Oligonucleotide Therapy Product
Table 50. Alnylam Pharmaceuticals Inc. Revenue in Oligonucleotide Therapy Business (2020-2025) & (US$ Million)
Table 51. Alnylam Pharmaceuticals Inc. Recent Development
Table 52. Biogen Company Details
Table 53. Biogen Business Overview
Table 54. Biogen Oligonucleotide Therapy Product
Table 55. Biogen Revenue in Oligonucleotide Therapy Business (2020-2025) & (US$ Million)
Table 56. Biogen Recent Development
Table 57. Dynavax Technologies Corp. Company Details
Table 58. Dynavax Technologies Corp. Business Overview
Table 59. Dynavax Technologies Corp. Oligonucleotide Therapy Product
Table 60. Dynavax Technologies Corp. Revenue in Oligonucleotide Therapy Business (2020-2025) & (US$ Million)
Table 61. Dynavax Technologies Corp. Recent Development
Table 62. Merck and Co. Company Details
Table 63. Merck and Co. Business Overview
Table 64. Merck and Co. Oligonucleotide Therapy Product
Table 65. Merck and Co. Revenue in Oligonucleotide Therapy Business (2020-2025) & (US$ Million)
Table 66. Merck and Co. Recent Development
Table 67. Miragen Therapeuutics Inc. Company Details
Table 68. Miragen Therapeuutics Inc. Business Overview
Table 69. Miragen Therapeuutics Inc. Oligonucleotide Therapy Product
Table 70. Miragen Therapeuutics Inc. Revenue in Oligonucleotide Therapy Business (2020-2025) & (US$ Million)
Table 71. Miragen Therapeuutics Inc. Recent Development
Table 72. Sarepta Therapeutics Inc. Company Details
Table 73. Sarepta Therapeutics Inc. Business Overview
Table 74. Sarepta Therapeutics Inc. Oligonucleotide Therapy Product
Table 75. Sarepta Therapeutics Inc. Revenue in Oligonucleotide Therapy Business (2020-2025) & (US$ Million)
Table 76. Sarepta Therapeutics Inc. Recent Development
Table 77. GlaxoSmithKline Company Details
Table 78. GlaxoSmithKline Business Overview
Table 79. GlaxoSmithKline Oligonucleotide Therapy Product
Table 80. GlaxoSmithKline Revenue in Oligonucleotide Therapy Business (2020-2025) & (US$ Million)
Table 81. GlaxoSmithKline Recent Development
Table 82. Pfizer Company Details
Table 83. Pfizer Business Overview
Table 84. Pfizer Oligonucleotide Therapy Product
Table 85. Pfizer Revenue in Oligonucleotide Therapy Business (2020-2025) & (US$ Million)
Table 86. Pfizer Recent Development
Table 87. Gilead Sciences Company Details
Table 88. Gilead Sciences Business Overview
Table 89. Gilead Sciences Oligonucleotide Therapy Product
Table 90. Gilead Sciences Revenue in Oligonucleotide Therapy Business (2020-2025) & (US$ Million)
Table 91. Gilead Sciences Recent Development
Table 92. Research Programs/Design for This Report
Table 93. Key Data Information from Secondary Sources
Table 94. Key Data Information from Primary Sources
Table 95. Authors List of This Report
List of Figures
Figure 1. Oligonucleotide Therapy Picture
Figure 2. Global Oligonucleotide Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Oligonucleotide Therapy Market Share by Type: 2024 VS 2031
Figure 4. Antisense Oligonucleotide Features
Figure 5. Aptamer Features
Figure 6. Others Features
Figure 7. Global Oligonucleotide Therapy Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Oligonucleotide Therapy Market Share by Application: 2024 VS 2031
Figure 9. Infectious Diseases Case Studies
Figure 10. Oncology Case Studies
Figure 11. Neurodegenerative Disorders Case Studies
Figure 12. Cardiovascular Diseases Case Studies
Figure 13. Kidney Diseases Case Studies
Figure 14. Others Case Studies
Figure 15. Oligonucleotide Therapy Report Years Considered
Figure 16. Global Oligonucleotide Therapy Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 17. Global Oligonucleotide Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 18. Global Oligonucleotide Therapy Market Share by Region: 2024 VS 2031
Figure 19. Global Oligonucleotide Therapy Market Share by Players in 2024
Figure 20. Global Top Oligonucleotide Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oligonucleotide Therapy as of 2024)
Figure 21. The Top 10 and 5 Players Market Share by Oligonucleotide Therapy Revenue in 2024
Figure 22. North America Oligonucleotide Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. North America Oligonucleotide Therapy Market Share by Country (2020-2031)
Figure 24. United States Oligonucleotide Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Canada Oligonucleotide Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Oligonucleotide Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Europe Oligonucleotide Therapy Market Share by Country (2020-2031)
Figure 28. Germany Oligonucleotide Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. France Oligonucleotide Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. U.K. Oligonucleotide Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Italy Oligonucleotide Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Russia Oligonucleotide Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Nordic Countries Oligonucleotide Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Oligonucleotide Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Asia-Pacific Oligonucleotide Therapy Market Share by Region (2020-2031)
Figure 36. China Oligonucleotide Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Japan Oligonucleotide Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. South Korea Oligonucleotide Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Southeast Asia Oligonucleotide Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. India Oligonucleotide Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Australia Oligonucleotide Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Oligonucleotide Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Latin America Oligonucleotide Therapy Market Share by Country (2020-2031)
Figure 44. Mexico Oligonucleotide Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Brazil Oligonucleotide Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Oligonucleotide Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Middle East & Africa Oligonucleotide Therapy Market Share by Country (2020-2031)
Figure 48. Turkey Oligonucleotide Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Saudi Arabia Oligonucleotide Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. UAE Oligonucleotide Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Alnylam Pharmaceuticals Inc. Revenue Growth Rate in Oligonucleotide Therapy Business (2020-2025)
Figure 52. Biogen Revenue Growth Rate in Oligonucleotide Therapy Business (2020-2025)
Figure 53. Dynavax Technologies Corp. Revenue Growth Rate in Oligonucleotide Therapy Business (2020-2025)
Figure 54. Merck and Co. Revenue Growth Rate in Oligonucleotide Therapy Business (2020-2025)
Figure 55. Miragen Therapeuutics Inc. Revenue Growth Rate in Oligonucleotide Therapy Business (2020-2025)
Figure 56. Sarepta Therapeutics Inc. Revenue Growth Rate in Oligonucleotide Therapy Business (2020-2025)
Figure 57. GlaxoSmithKline Revenue Growth Rate in Oligonucleotide Therapy Business (2020-2025)
Figure 58. Pfizer Revenue Growth Rate in Oligonucleotide Therapy Business (2020-2025)
Figure 59. Gilead Sciences Revenue Growth Rate in Oligonucleotide Therapy Business (2020-2025)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
